Measles Vaccination Cash Incentives Experimental Evidence From Nigeria

NCT04013516 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1088

Last updated 2019-07-09

No results posted yet for this study

Summary

IDinsight is conducting a randomized controlled trial to assess the impact of various sized cash incentives for caretakers of infants that require a 9-month measles vaccination on the completion rate for the vaccine in Nigeria. The purpose of the experiment is to help New Incentives (NI) determine the optimal size of the incentive as they scale to the North West region of Nigeria.

Conditions

Interventions

BEHAVIORAL

Cash Incentive

During the phone call, New Incentives' team member promised a greater cash payment from New Incentives' staff members at primary health care facilities when infants enrolled in the program and received their measles vaccination.

BEHAVIORAL

Call

A New Incentives' team member reminded caregivers of their child's measles immunization date and the total amount of incentive they would receive once their child was vaccinated. If the caregiver could not be reached on the first attempt, the team made additional attempts at different times of the day on five different days across two weeks (up to 10 attempts were made per caregiver).

Sponsors & Collaborators

  • GiveWell

    collaborator OTHER
  • IDinsight

    lead OTHER

Principal Investigators

  • Alison Connor · IDinsight

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
9 Months
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-05-12
Primary Completion
2017-09-11
Completion
2017-09-11

Countries

  • Nigeria

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04013516 on ClinicalTrials.gov